We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.
Researchers have published a comprehensive review of configuration and parameter design for electrified propulsion systems in ...
Explore the recent advances in fuzzing, including the challenges and opportunities it presents for high-integrity software ...
Morning Overview on MSN
New AI tool aims to speed diagnosis of rare genetic diseases
When a child’s symptoms stump one specialist after another for years on end, families describe the experience as grueling and ...
It could behoove Savannah Guthrie to pay up, according to a former FBI agent. In an interview published on Friday, April 10, ...
To this day, in the known universe, only one example exists of a system capable of general-purpose intelligence. That system ...
Explore how advances in accuracy, throughput and cost are making long-read sequencing more accessible at scale.
At the heart of the integrated Biofunctional Imaging and Therapeutics Lab at Tufts University is a passion for improving ...
Master ultra-high-throughput screening principles. Learn how advanced automation and miniaturization accelerate drug ...
This week in oncology, regulatory updates and practice-changing trial data took center stage. From FDA timeline extensions to ...
Good afternoon, and welcome to the Travere Therapeutics Business Update Conference Call. Today's call is being recorded. At this time, I would like to turn the conference call over to Nivi Nehra, Vice ...
Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results